|
Agency Priority Goals Maternal Health
|
Committee, Work group, Advisory group, or Task Force
|
HRSA, NIH, ASPE, CDC, CMS, FDA, OASH, ACF, OGA, AHRQ, ACL
|
NICHD, OD/DPCPSI/ORWH, OD/IMOD, OD/DPCPSI/OEPR
|
HHS-wide group to set an impact statement and priority goals regarding maternal morbidity and mortality.
|
|
Alaska Native Tumor Registry
|
Resource Development
|
CDC, IHS
|
NCI
|
In collaboration with the Centers for Disease Control and Prevention (CDC), Indian Health Service (IHS), and National Cancer Institute (NCI), and with technical assistance from the Surveillance, Epidemiology, and End Results Program (SEER), the Alaska Native Tumor Registry collects cancer information on all American Indian and Alaska Native people residing in Alaska at the time of diagnosis.
|
|
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
|
Research Initiative
|
FDA
|
NIAAA
|
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
|
|
All of Us IAA with CDC Office of Public Health Genomics
|
Other
|
CDC
|
OD/AoU
|
Interagency Agreement between CDC and NIH to support translational work
|
|
Alzheimers.gov Collaborations with Federal Agencies
|
Public Education Campaign
|
ACL, ASPA, ASPE, CDC
|
NIA, NINDS
|
In the course of developing the new English and Spanish Alzheimers.gov websites, NIA consulted with the NAPA Federal Subgroup on website content, usability, and outreach, including working with NINDS, ACL, and CDC to review website content.
|
|
American Academy of Pediatrics (AAP) Committee on Drugs
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NICHD
|
The AAP Committee on Drugs reviews all aspects of pediatric pharmacology, including drug indications, contraindications, absorption rates, routes of administration, dosing, use precautions, and mode of action as they apply to children. The Committee also advises the Board of Directors in matters related to drug labeling, safety, and efficacy for both prescription and over-the-counter drugs; monitors federal legislation related to the drug approval process; and promotes the need for expanded pediatric drug trials.
|
|
American Academy of Pediatrics (AAP) Committee on Nutrition
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NICHD
|
The Committee on Nutrition (CON) studies the nutritional needs of infants, children, and adolescents and develops guidelines for the pediatrician based on sound, objective, clinical science as well as practical experience in fostering optimal health status. CON also maintains active liaisons with the Food and Drug Administration, United States Department of Agriculture (USDA), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and the Canadian Paediatric Society, pursues advocacy opportunities which promote healthy dietary habits; and provides technical assistance as needed relative to the federal regulatory process.
|
|
American Academy of Pediatrics (AAP) Committee on Pediatric AIDS (AAP-COPA)
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NICHD
|
The Committee on Pediatric AIDS (COPA) provides guidelines and recommendations for the care and treatment of infants, children, and adolescents with HIV and their families through the development of AAP Policy Statements.
|
|
American Academy of Pediatrics (AAP) Council on Genetics (AAP-COG)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA
|
NICHD
|
The AAP Council on Genetics (COG) studies and makes recommendations to the AAP Board of Directors on recent advances in genetics and provides support to chapters on state legislative issues as they relate to genetics.
|
|
American Academy of Pediatrics (AAP) Section on Obesity (AAP-SOO)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NICHD
|
The Section on Obesity's mission is to improve the health and well-being of children and families by reducing the prevalence of childhood obesity and promoting healthy active living.
|